Low density multiparticulate system for pulsatile release of meloxicam

International Journal of Pharmaceutics

Volumn 313, Issue 1-2, 2006, Pages 150-158

  Sharma, Sameer ^a   Pawar, Atmaram ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Floating pulsatile drug delivery system; Meloxicam; Porous calcium silicate; Rheumatoid arthritis

Indexed keywords

ALGINIC ACID; CALCIUM SILICATE; MELOXICAM;

ARTICLE; CRUSHING STRENGTH; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GELATION; HYDROPHOBICITY; INTESTINE FLUID; PARTICULATE MATTER; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; RHEUMATOID ARTHRITIS;

ALGINATES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; KINETICS; PARTICLE SIZE; POROSITY; SILICATES; SOLUBILITY; SURFACE PROPERTIES; THIAZINES; THIAZOLES;

EID: 33645321628     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.001     Document Type: Article

References (41)

1. Y. Akiyama, N. Nagahara, E. Nara, M. Kitano, S. Iwasa, I. Yamamoto, J. Azuma, and Y. Ogawa Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites J. Pharm. Pharmacol. 50 1998 159 166
2. A. Basit, and L. Lacey Colonic metabolism of ranitidine: implications for its delivery and absorption Int. J. Pharm. 227 2001 157 165
3. S. Bolton Pharmaceutical Statistics: Practical and Clinical Applications 3rd ed. 1997 Marcel Dekker New York
4. R.S. Byrne, and P.B. Deasy Use of commercial porous ceramic particles for sustained drug delivery Int. J. Pharm. 246 2002 61 73
5. A. Charloux, C. Gronfier, E. Lonsdorfer-Wolf, F. Piquard, and G. Brandenberger Aldosterone release during the sleep-wake cycle in humans Am. J. Physiol. 276 1999 E43 E49
6. L.J. Crofford, K.T. Kalogeras, G. Mastorakos, M.A. Magiakou, K.S. Kanik, P.W. Gold, G.P. Chrousos, and R.L. Wilder Circadian relationships between interleukin (IL)-6 and hypothalamic-pitutary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis J. Clin. Endocr. Metab. 82 1997 1279 1283
7. M. Cutolo, B. Seriolo, C. Craviotto, C. Pizzorni, and A. Sulli Circadian rhythms in RA Ann. Rheum. Dis. 62 2003 593 596
8. S.S. Davis Formulation strategies for absorption windows Drug Discov. Today 10 2005 249 257
9. J.T. Flaherty Nitrate tolerance: a review of the evidence Drugs 37 1989 523 550
10. A. Gazzaniga, C. Busetti, L. Moro, T. Crimella, M.E. Sangalli, and F. Giordano Evaluation of viscosity HPMC as retarding coating material in the preparation of a time-based oral colon specific delivery system Proc. Int. Symp. Control. Rel. Bioact. Mater. 22 1995 242 243
11. Ghorab, M.M., Abdel-Salem, H.M., El-Sayad, M.A., Mohammed M.M., 2004. Tablet formulation containing meloxicam and β-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 5, article 59.
12. P.D. Goldenheim, E.A. Conrad, and L.K. Schein Treatment of asthma by a controlled release theophylline tablet formulation: a review of the North American experience with nocturnal dosing Chronobiol. Int. 4 1987 397 408
13. T. Hanawa, R. Ikoma, A. Watanabe, M. Hidaka, and M. Sugihara Preparation and characterization of sealed heated mixture of ethenzamide and porous calcium silicate Chem. Pharm. Bull. 44 1996 1367 1371
14. Harrigan, R.N., 1977. Drug delivery device for preventing contact of undissolved drug with the stomach lining. US Patent 4,055,178 (October 25).
15. A. Hoffman, D. Stepensky, E. Lavy, S. Eyal, E. Klausner, and M. Friedman Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms Int. J. Pharm. 277 2004 141 153
16. Y. Ito, H. Arai, K. Uchino, K. Iwasaki, N. Shibata, and K. Takada Effect of adsorbents on the absorption of lansoprazole with surfactant Int. J. Pharm. 289 2005 69 77
17. P.J. Jarosz, and E.J. Parrott Comparison of granule strength and tablet strength J. Pharm. Sci. 72 1983 530 535
18. A.G. Jimoh, D.L. Wise, J.D. Gresser, and D.J. Trantolo Pulsed FSH release from an implantable capsule system J. Control. Rel. 34 1995 87 95
19. Y. Kawashima, T. Niwa, H. Takeuchi, T. Hino, and Y. Ito Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo) J. Control. Rel. 16 1991 279 290
20. A. Kikuchi, and T. Okano Pulsatile drug release control using hydrogels Adv. Drug Del. Rev. 54 2002 53 77
21. M. Kinoshita, K. Baba, A. Nagayasu, K. Yamabe, M. Azuma, H. Houchi, and K. Minakuchi Highly stabilized amorphous 3-bis(4-Methoxyphenyl)methylene-2- indolinone (TAS-301) in melt-adsorbed products with silicate compounds Drug Deliv. Ind. Pharm. 29 2003 523 529
22. N. Nagahara, Y. Akiyama, M. Nako, M. Tada, M. Kitano, and Y. Ogawa Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori Antimicrob. Agent Chemother. 42 1998 2492 2494
23. K. Niwa, T. Takaya, T. Morimoto, and K. Takada Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs J. Drug Target. 3 1995 83 89
24. T. Ostberg, E.M. Lund, and C. Graffner Calcium alginate matrices for oral multiple unit administration. IV. Release characteristics in different media Int. J. Pharm. 112 1994 241 248
25. J.O. Parker, H.L. Fung, D. Rugginello, and J.A. Stone Tolerance to isosorbide dinitrate: rate of development and reversal Circulation 68 1983 1074 1080
26. V. Pillay, and R. Fassihi In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract I. Comparison of pH-responsive drug release and associated kinetics J. Control. Rel. 59 1999 229 242
27. W.A. Ritschel Targeting in the gastrointestinal tract: new approaches. Methods Find Exp. Clin. Pharmacol. 13 1991 313 336
28. L.J. Roberts II, and J.D. Morrow Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout J.G. Hardman L.E. Limbird Goodman and Gilman's The Pharamcological Basis of Therapeutics 2001 McGraw-Hill New York 713 714
29. N. Rouge, P. Buri, and E. Doelker Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery Int. J. Pharm. 136 1996 117 139
30. A. Rubinstein, B. Tirosh, M. Baluom, T. Nassar, A. David, R. Radai, I. Gliko-Kabir, and M. Friedman The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools J. Control. Rel. 46 1997 59 73
31. T. Sawada, H. Kondo, H. Nakashima, K. Sako, and M. Hayashi Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy Int. J. Pharm. 280 2004 103 111
32. T. Sawada, K. Sako, K. Yoshihara, K. Nakamura, S. Yokohama, and M. Hayashi Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam J. Pharm. Sci. 92 2003 790 797
33. B.N. Singh, and K.H. Kim Floating drug delivery system: an approach to oral controlled drug delivery via gastric retention J. Control. Rel. 63 2000 235 259
34. Stehlin, I., 1997. A time to heal: chronotherapy tunes in to body's rhythms. FDA Consumer magazine, April.
35. A. Streubel, J. Siepmann, and R. Bodmeier Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release Eur. J. Pharm. Sci. 18 2003 37 45
36. E. Terasawa, K.L. Keen, K. Mogi, and P. Claude Pulsatile release of luteinizing hormone-release (LHRH) in cultured LHRH neurons derived from the embryolic olfactory placode of the rhesus monkey Endocrinology 140 1999 1432 1441
37. Umezawa, H., 1978. Pepstatin floating minicapsules. US Patent 4,101,650 (July 18).
38. L. Whitehead, J.T. Fell, J.H. Collett, H.L. Sharma, and A.M. Smith Floating dosage forms: an in vivo study demonstrating prolonged gastric retention J. Control. Rel. 55 1998 3 12
39. H. Yuasa, D. Asahi, Y. Takashima, Y. Kanaya, and K. Shinozawa Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate Chem. Pharm. Bull. 42 1994 2327 2331
40. H. Yuasa, Y. Takashima, and Y. Kanaya Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier Chem. Pharm. Bull. 44 1996 1361 1366
41. H. Yuasa, M. Akutagawa, T. Hashizume, and Y. Kanaya Studies on internal structure of tablets. VI. Stress dispersion in tablets by excipients Chem. Pharm. Bull. 44 1996 378 382